PNC Financial Services Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
CC
CWG
JJ
PNC Financial Services Group's PRCT Position: Q2 2026 in Review
PNC Financial Services Group increased its Procept Biorobotics (PRCT) stake by 272% in Q2 2026, buying an estimated $8.44K and bringing the position to 461 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.
PNC Financial Services Group first reported a position in PRCT in Q2 2022 and has held it in 12 quarters since. The position peaked at $863K in Q2 2022. 98 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.
- PNC Financial Services Group held 461 shares of Procept Biorobotics worth $10.4K as of Q2 2026.
- PNC Financial Services Group bought 337 Procept Biorobotics shares in Q2 2026, an estimated $8.44K.
- Procept Biorobotics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4068 holding.
- PNC Financial Services Group first reported a position in Procept Biorobotics in Q2 2022 and has held it in 12 quarters since.
- PNC Financial Services Group's Procept Biorobotics position peaked at $863K in Q2 2022.
- 98 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.